This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor.—Dr Campbell and colleagues¹ highlight the potential conflicts of interest that reside in innocuous-appearing gifts from industry to university researchers and encourage the use and revision of institutional policies by faculty. As Dr Bero² points out in the accompanying Editorial, one major problem with this approach is different perceptions as to what constitutes a conflict. Although Bero refers to disagreements between basic and clinical researchers, there are other relevant stakeholders. In a recent study by Gibbons et al,³ patients tended to view pharmaceutical company gifts to physicians as far more alarming and as posing a significantly greater conflict of interest than did physicians. The potential for such differing perceptions argues for making the goals of any policy as clear and as explicit as possible and for encouraging academic-industry research relationships primarily in areas where the 2 interests are clearly aligned.

Although the importance of resolving conflicts of . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Looking a Gift Horse in the Mouth: Corporate Gifts Supporting Life Sciences Research
Eric G. Campbell, Karen Seashore Louis, and David Blumenthal
JAMA. 1998;279(13):995-999.
ABSTRACT | FULL TEXT